Skip to content

Effects of Internet Support for Cancer Patients

Effects of Internet Support for Cancer Patients on Health Outcomes, Health Care Utilization and Costs: A Randomized Clinical Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00971009
Acronym
WebChoice 2
Enrollment
200
Registered
2009-09-03
Start date
2010-03-31
Completion date
2015-07-31
Last updated
2015-10-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast Cancer

Keywords

Symptom management, Interactive Health Communication Application, Patient-provider communication, Health care costs

Brief summary

Being diagnosed and treated for cancer is usually associated with severe physical symptoms, impaired functional status, complex emotional, psychosocial and existential issues and substantial worries. Failure to help patients with their problems and worries can unnecessarily delay patients' recovery and rehabilitation, lead to chronic functional impairments, anxiety and depression and prolong patients' needs for health care and social services. The objectives of this interdisciplinary, international research project that includes collaboration with HELFO (The Norwegian Health Economy Administration), are to test and compare, in a randomized, controlled trial (RCT), the effects of (1) a practice-integrated online patient-provider communication (OPPC) service including access to asking questions to HELFO, (2) a multi-component Interactive Health Communication Application (IHCA) called WebChoice, and (3) usual care on: patient outcomes, health care and social services use and costs. Breast cancer patients undergoing treatment at three different hospitals in Norway will be randomized into two experimental and one control groups and will be followed with 5 repeated measures over one year. The proposed study will contribute to innovative methods and technologies that can radically improve patient-provider communication, care quality, and continuity of care. The two interventions tested in this study, the OPPC service with and without additional features of WebChoice, represent new forms of interactions and information sharing between patients and clinicians where patients can get seamless access to communication and information services from where and whenever they need it. This could significantly contribute to reducing unnecessary suffering, less fragmented health care, better efficiency, patient safety, patient satisfaction and have an impact on patients' health services utilization. The investigators' work addresses, therefore, important health policy goals with the potential for considerable societal gains.

Interventions

BEHAVIORALOPPC service

Access to a practice-integrated nurse administered online patient-provider communication (OPPC) service including access to asking questions to social counselors

BEHAVIORALWebChoice IHCA

The additional features of WebChoice allows patients to monitor their symptoms and health problems from home; provides them with individually tailored, just-in-time information and support to manage their symptoms and illness-related problems between treatments and during rehabilitation; and a forum, or e-group community, for group discussion with other cancer patients.

Sponsors

South-Eastern Norway Regional Health Authority
CollaboratorOTHER
Oslo University Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients recently diagnosed with breast cancer and under treatment (radiation, chemotherapy, hormone, or combinations of those) * Patients are \> 18 years of age, able to write / read / speak Norwegian and have Internet with secure access (BankID) at home

Exclusion criteria

* Excluded are patients who had received radiation on the brain as this may affect their abilities to reliably report their symptoms

Design outcomes

Primary

MeasureTime frame
Severity and duration of symptom distressAt baseline and at 2, 4, 6, 8 and 12 months
Anxiety and depressionAt baseline an at 2, 4, 6, 8 and 12 months

Secondary

MeasureTime frame
Self-efficacyAt baseline and at 2, 4, 6, 8 and 12 months
Uncertainty in illnessAt baseline and at 2, 4, 6, 8 and 12 months
Health care costsPost intervention, at 12 and 18 months
Quality of lifeAt baseline and at 4, 8 and 12 months

Countries

Norway

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 6, 2026